CN Stock MarketDetailed Quotes
603963 Dali Pharmaceutical
- 3.31
- +0.01+0.30%
Market Closed Sep 5 15:00 CST
727.21MMarket Cap-34123P/E (TTM)
3.40High3.14Low97.16KlotVolume3.15Open3.30Pre Close31.65MTurnover4.42%Turnover RatioLossP/E (Static)219.70MShares15.9752wk High1.97P/B727.21MFloat Cap2.2852wk Low3.47Limit Up219.70MShs Float21.25Historical High3.14Limit Down7.88%Amplitude2.28Historical Low--Dividend TTM3.26Avg Price39.15KlotAsk--Div YieldTTM100Lot Size55.29KlotBid
Dali Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -36.52%42.01M | -71.82%10.93M | -18.85%121.13M | -25.50%82.01M | -12.22%66.18M | -5.61%38.77M | -24.51%149.27M | -24.99%110.08M | -26.63%75.4M | -21.66%41.07M |
| Refunds of taxes and levies | --1.44M | --1.44M | ---- | ---- | ---- | ---- | --251.83K | ---- | ---- | ---- |
| Cash received relating to other operating activities | -32.94%1.44M | -52.01%1.04M | 64.12%8.08M | 358.53%8.63M | 62.33%2.14M | 328.08%2.16M | 9.77%4.92M | -47.60%1.88M | -47.98%1.32M | -57.39%504K |
| Cash inflows from operating activities | -34.30%44.89M | -67.26%13.4M | -16.34%129.21M | -19.04%90.64M | -10.94%68.32M | -1.56%40.93M | -23.63%154.44M | -25.53%111.96M | -27.15%76.71M | -22.45%41.57M |
| Goods services cash paid | -46.63%13.94M | -36.76%7.16M | 66.22%70.17M | 50.54%48.94M | 2.67%26.13M | -19.65%11.33M | 36.02%42.21M | 28.76%32.51M | 13.32%25.45M | 15.34%14.1M |
| Staff behalf paid | -14.01%10.71M | -22.76%5.1M | -14.46%23.42M | -13.20%17.51M | -13.13%12.46M | -0.93%6.6M | -5.48%27.38M | -6.87%20.17M | -7.05%14.34M | 1.37%6.66M |
| All taxes paid | -67.76%3.51M | -55.56%3.02M | -3.30%12.23M | 27.73%11.75M | 181.58%10.9M | 85.88%6.79M | -37.88%12.65M | -42.29%9.2M | -65.15%3.87M | -22.10%3.65M |
| Cash paid relating to other operating activities | -67.12%12.76M | -84.12%3.4M | -34.94%49.39M | -27.55%45.55M | -8.99%38.81M | -8.24%21.42M | -31.81%75.92M | -31.15%62.88M | -34.12%42.64M | -27.13%23.34M |
| Cash outflows from operating activities | -53.64%40.93M | -59.51%18.68M | -1.87%155.22M | -0.80%123.75M | 2.31%88.28M | -3.39%46.13M | -17.50%158.17M | -19.08%124.75M | -24.11%86.29M | -13.98%47.75M |
| Net cash flows from operating activities | 119.83%3.96M | -1.39%-5.28M | -597.47%-26.01M | -158.89%-33.1M | -108.38%-19.96M | 15.67%-5.21M | -135.48%-3.73M | -234.42%-12.79M | -13.95%-9.58M | -224.70%-6.17M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 7.93%245M | 50.00%150M | 34.57%362M | 132.58%307M | 71.97%227M | --100M | -43.96%269M | -45.00%132M | -45.00%132M | ---- |
| Cash received from returns on investments | -22.46%3.1M | -2.05%2.11M | 43.99%5.93M | 151.30%5.23M | 92.26%4M | --2.15M | -39.99%4.12M | -46.85%2.08M | -46.85%2.08M | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -69.88%40K | ---- | --132.8K | --132.8K | --132.8K | --132.8K | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 7.36%248.14M | 48.71%152.11M | 34.76%368.06M | 132.97%312.37M | 72.38%231.14M | --102.29M | -43.90%273.12M | -45.03%134.08M | -45.03%134.08M | ---- |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -71.39%1.34M | -53.33%1.09M | -73.88%7.7M | -54.42%5.48M | -52.13%4.69M | -71.76%2.34M | 21.82%29.47M | -36.86%12.03M | -24.70%9.8M | 46.21%8.27M |
| Cash paid to acquire investments | -11.11%120M | 50.00%120M | -6.59%340M | 20.25%285M | -43.04%135M | -20.00%80M | -2.15%364M | -1.25%237M | -1.25%237M | --100M |
| Cash outflows from investing activities | -13.14%121.34M | 47.07%121.09M | -11.63%347.7M | 16.65%290.48M | -43.40%139.69M | -23.95%82.34M | -0.69%393.47M | -3.87%249.03M | -2.46%246.8M | 1,813.81%108.27M |
| Net cash flows from investing activities | 38.67%126.8M | 55.48%31.02M | 116.92%20.36M | 119.04%21.89M | 181.12%91.44M | 118.43%19.95M | -232.75%-120.36M | -659.84%-114.94M | -1,138.63%-112.72M | -1,813.81%-108.27M |
| Financing cash flow | ||||||||||
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | -62.50%15M | ---- | ---- | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | ---- | -62.50%15M | ---- | ---- | ---- |
| Borrowing repayment | -71.43%3.5M | ---- | -15.06%19.75M | 104.16%12.25M | 104.16%12.25M | ---- | 132.50%23.25M | 100.00%6M | 100.00%6M | ---- |
| Dividend interest payment | -47.72%499.69K | -47.89%252.69K | -25.92%1.64M | -21.85%1.3M | -17.11%955.86K | -15.50%484.89K | -80.94%2.21M | -85.16%1.67M | -89.28%1.15M | 94.99%573.81K |
| Cash payments relating to other financing activities | -38.09%1.55M | ---- | 14.89%2.61M | --2.5M | --2.5M | --2.5M | 0.73%2.27M | ---- | ---- | ---- |
| Cash outflows from financing activities | -64.68%5.55M | -91.54%252.69K | -13.46%24M | 109.37%16.06M | 119.60%15.71M | 420.60%2.99M | 16.29%27.73M | -46.16%7.67M | -48.00%7.15M | 94.99%573.81K |
| Net cash flows from financing activities | 64.68%-5.55M | 91.54%-252.69K | -88.46%-24M | -109.37%-16.06M | -119.60%-15.71M | -420.60%-2.99M | -178.85%-12.73M | -233.24%-7.67M | -90.38%-7.15M | -105.91%-573.81K |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 124.49%125.21M | 116.80%25.49M | 78.33%-29.65M | 79.86%-27.27M | 143.08%55.77M | 110.22%11.76M | -216.62%-136.82M | -926.14%-135.4M | -508.79%-129.45M | -5,457.47%-115.02M |
| Add:Begin period cash and cash equivalents | -67.62%14.19M | -67.62%14.19M | -75.73%43.84M | -75.73%43.84M | -75.73%43.84M | -75.73%43.84M | 185.25%180.66M | 185.25%180.66M | 185.25%180.66M | 185.25%180.66M |
| End period cash equivalent | 39.95%139.4M | -28.63%39.68M | -67.62%14.19M | -63.40%16.57M | 94.54%99.61M | -15.30%55.6M | -75.73%43.84M | -9.73%45.26M | 21.72%51.21M | 0.24%65.64M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg